MedPath

Lithium cation

Generic Name
Lithium cation
Drug Type
Small Molecule
Chemical Formula
Li
CAS Number
7439-93-2
Unique Ingredient Identifier
8H8Z5UER66
Background

Lithium was used during the 19th century to treat gout. Lithium salts such as lithium carbonate (Li2CO3), lithium citrate, and lithium orotate are mood stabilizers. They are used in the treatment of bipolar disorder, since unlike most other mood altering drugs, they counteract both mania and depression. Lithium can also be used to augment other antidepressant drugs. It is also sometimes prescribed as a preventive treatment for migraine disease and cluster headaches. The active principle in these salts is the lithium ion Li+, which having a smaller diameter, can easily displace K+ and Na+ and even Ca+2, in spite of its greater charge, occupying their sites in several critical neuronal enzymes and neurotransmitter receptors.

Indication

Lithium, in its salt forms, is used as a mood stabilizer and for the treatment of depression and mania. It is most frequently prescribed in the treatment of bipolar disorder.

Associated Conditions
Bipolar Disorder (BD), Depression, Depression, Bipolar, Acute Manic episode

Treatment and Outcome of Early Onset Bipolar Disorder

Phase 4
Completed
Conditions
Bipolar Disorder
First Posted Date
2002-11-13
Last Posted Date
2014-01-22
Lead Sponsor
Northwell Health
Target Recruit Count
40
Registration Number
NCT00048802
Locations
🇺🇸

The Zucker Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, New York, United States

Optimizing Electroconvulsive Therapy for Depression

Phase 4
Completed
Conditions
Depression
Depressive Disorder
Bipolar Disorder
Interventions
Procedure: High dosage electroconvulsive therapy
Procedure: Low dosage electroconvulsive therapy
First Posted Date
2002-09-17
Last Posted Date
2013-08-13
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
340
Registration Number
NCT00045916
Locations
🇺🇸

Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States

🇺🇸

New York State Psychiatric Institute at Columbia University, New York, New York, United States

🇺🇸

Wake Forest University, Winston-Salem, North Carolina, United States

and more 1 locations

Relapse Prevention for Bipolar Type-II Disorder

Phase 4
Completed
Conditions
Depression
Bipolar Disorder
First Posted Date
2002-09-05
Last Posted Date
2015-10-06
Lead Sponsor
University of Pennsylvania
Target Recruit Count
180
Registration Number
NCT00044616
Locations
🇺🇸

Depression Research Unit, Univ Penn, Philadelphia, Pennsylvania, United States

Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder

Recruiting
Conditions
Mood Disorder
Interventions
First Posted Date
2001-11-01
Last Posted Date
2025-05-16
Lead Sponsor
National Institute of Mental Health (NIMH)
Target Recruit Count
2350
Registration Number
NCT00025935
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Sequenced Treatment Alternatives to Relieve Depression (STAR*D)

Phase 4
Completed
Conditions
Depression
First Posted Date
2001-07-23
Last Posted Date
2009-09-25
Lead Sponsor
National Institute of Mental Health (NIMH)
Target Recruit Count
4000
Registration Number
NCT00021528
Locations
🇺🇸

Harbor UCLA Family Health Care Center, Harbor City, California, United States

🇺🇸

UCLA General Outpatient Psychiatry Clinic, Los Angeles, California, United States

🇺🇸

UCLA Internal Medicine Clinic, Los Angeles, California, United States

and more 38 locations

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Not Applicable
Completed
Conditions
Bipolar Disorder
First Posted Date
2001-03-15
Last Posted Date
2007-05-04
Lead Sponsor
National Institute of Mental Health (NIMH)
Target Recruit Count
5000
Registration Number
NCT00012558
Locations
🇺🇸

Case Western Reserve University, Cleveland, Ohio, United States

🇺🇸

University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States

🇺🇸

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

and more 8 locations

Long-Term Lithium Treatment for Aggressive Conduct Disorder

Phase 3
Completed
Conditions
Aggression
Conduct Disorder
Interventions
Drug: Placebo
First Posted Date
1999-11-03
Last Posted Date
2013-11-26
Lead Sponsor
Drexel University
Target Recruit Count
59
Registration Number
NCT00000385
Locations
🇺🇸

Drexel University College of Medicine at Friends Hospital, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath